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Abstract
Background: White matter hyperintensities (WMH) on
MRI scans indicate lesions of the subcortical fiber sys-
tem. The regional distribution of WMH may be related to
their pathophysiology and clinical effect in vascular de-
mentia (VaD), Alzheimer’s disease (AD) and healthy
aging. Methods: Regional WMH volumes were mea-
sured in MRI scans of 20 VaD patients, 25 AD patients
and 22 healthy elderly subjects using FLAIR sequences
and surface reconstructions from a three-dimensional
MRI sequence. Results: The intraclass correlation coeffi-
cient for interrater reliability of WMH volume measure-
ments ranged between 0.99 in the frontal and 0.72 in the
occipital lobe. For each cerebral lobe, the WMH index,
i.e. WMH volume divided by lobar volume, was highest
in VaD and lowest in healthy controls. Within each
group, the WMH index was higher in frontal and parietal
lobes than in occipital and temporal lobes. Total WMH
index and WMH indices in the frontal lobe correlated sig-
nificantly with the MMSE score in VaD. Category fluency
correlated with the frontal lobe WMH index in AD, while
drawing performance correlated with parietal and tem-
poral lobe WMH indices in VaD. Conclusions: A similar
regional distribution of WMH between the three groups
suggests a common (vascular) pathogenic factor leading
to WMH in patients and controls. Our findings under-
score the potential of regional WMH volumetry to deter-
mine correlations between subcortical pathology and
cognitive impairment.
Copyright © 2004 S. Karger AG, Basel
Introduction
Clinicopathological studies indicate that diffuse hyper-
intensities in the deep subcortical white matter (so-called
white matter hyperintensities, WMH) on T2-weighted
magnetic resonance imaging (MRI) scans represent isch-
emic damage of the subcortical fiber system [1–3]. Diffuse
WMH are most prevalent in vascular dementia (VaD) [4]
but are also reported in 27–92% of the elderly population
[5, 6]. An increase in WMH in patients with Alzheimer’s
disease (AD) compared to age-matched healthy elderly
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Table 1. Subjects’ characteristics
Variable Controls
mean SD
AD
mean SD
VaD
mean SD
Age1, years 60.9 8.7 69.1 10.8 72.3 10.2
Range 50.1–79.1 35.4–86.2 48.3–85.4
MMSE2 29.6 0.6 18.7 5.8 21.4 4.8
Range 28–30 5–28 10–27
Gender3
Female 12 13 7
Male 10 12 13
Center4
Munich 17 19 8
Amsterdam 5 6 12
1 Significantly different between VaD and controls and AD and controls at p ! 0.01; not
different between AD and VaD, t = –1.02 with 43 d.f., p ! 0.32.
2 Significantly different between VaD and controls and AD and controls, Mann-Whitney U
test, p ! 0.001; different between AD and VaD, Mann-Whitney U test, p ! 0.10.
3 Not different between groups, ¯ 2 = 1.9 with 2 d.f., p ! 0.39.
4 Significantly different between groups, ¯ 2 = 8.3 with 2 d.f., p ! 0.02.
subjects is still controversial [4, 7, 8]. In the elderly popu-
lation, WMH increase with age, cerebrovascular disease
and hypertension [5, 9, 10].
Several studies reported a significant correlation be-
tween WMH and reduced performance in specific cogni-
tive domains in nondemented elderly subjects, particu-
larly in subjects with a history of hypertension [5, 10–12],
but these findings are controversial [13–15]. WMH have
been suggested to accelerate cognitive decline in individu-
als with mild cognitive impairment [16, 17] and were
related to reduced performance in several neuropsycho-
logical tasks in AD and VaD. Other studies failed to show
any relationship between WMH and cognition in AD [18]
or found no relationship between WMH and cognitive
performance independently of associated hippocampal
and cortical atrophy in a group of VaD and AD patients
[19, 20].
The regional distribution of WMH in different disor-
ders is of potential interest, because not only the extent,
but also the localization of a lesion determines its clinical
significance independently of the extent of the lesion. For
example, relatively small lesions in the thalamic nuclei
have strong effects on cognitive functioning [21], while
WMH widely distributed in the subcortical white matter
may remain clinically silent [22]. Furthermore, different
localizations of WMH may reflect pathogenic differences.
Neuropathological studies suggest a differential suscepti-
bility of cerebral regions for vascular pathology [23]. In
VaD, the frontal lobe appeared to be more vulnerable to
white matter pathology than other lobes [24–26].
So far, only few studies considered the regional distri-
bution of WMH in dementia [4] or aging [6]. These earlier
studies used semiquantitative rating scales, and these
studies did not always account for differences in lobar vol-
umes.
In this study, we used a semiautomated segmentation
technique to determine lobar WMH indices to be com-
pared between groups of VaD and AD patients and
healthy subjects. We also investigated whether lobar
WMH indices correlated with domain-specific cognitive
impairment and age.
Materials and Methods
Subjects
We studied 25 patients with the clinical diagnosis of probable AD
according to NINCDS-ADRDA criteria [27], 20 patients with the
clinical diagnosis of probable VaD according to NINDS-AIREN cri-
teria [28] and 22 healthy controls. Subjects were recruited from the
Department of Psychiatry, University of Munich, Germany, and the
Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam,
the Netherlands. Subject characteristics are presented in table 1.
Severity of dementia was determined according to the Mini Men-
tal State Examination (MMSE) score [29]. One AD patient was
severely demented (MMSE !10), 12 AD and 5 VaD patients were
moderately demented (9 ! MMSE !21), and 17 AD and 15 VaD
patients were mildly demented (MMSE 120). Dutch controls were
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recruited among spouses and friends of patients with dementia. The
Dutch controls completed the CAMCOG, the MMSE, the MADRS
and the CUSPAD. German controls were healthy volunteers re-
cruited from elderly members of a local parish. The German controls
completed the cognitive battery of the Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD), the HAMD and the
SIDAM. Exclusion criteria were history or presence of depression,
dementia or mild cognitive impairment and history or presence of
any other significant neurological, physical or psychiatric disorder
including drug and alcohol misuse.
Two Dutch controls had a history of hypertension but showed
normal values after treatment; German controls had no history of
hypertension and had normal blood pressure at the time of clinical
examination. Four German and 5 Dutch VaD patients had a history
of hypertension. Two German and 2 Dutch AD patients had a histo-
ry of hypertension but showed normal values after treatment.
The reliability of WMH measurement was evaluated in an inde-
pendent group of 10 German subjects. This group comprised 2
healthy elderly subjects, 6 patients with clinical probable AD and 2
patients with mixed dementia (mean age B SD was 74.9 B 8.4;
female-to-male ratio was 7/3).
Informed written consent was asked and received from all
patients and healthy subjects. Both ethical committees of the Ludwig
Maximilian University, Munich, Germany, and the Vrije Universi-
teit Amsterdam, The Netherlands, approved of the study.
Magnetic Resonance Imaging
MRI examinations were performed on a 1.5-tesla Siemens Mag-
netom Vision MRI scanner for the German subjects and on a 1.0-
tesla Siemens Magnetom Impact MRI scanner for the Dutch subjects
(both scanners from Siemens, Erlangen, Germany). All subjects had a
volumetric T1-weighted sagittally oriented MRI sequence (for Ger-
man subjects: TR = 11.6 ms, TE = 4.9 ms, resolution = 0.94 by 0.94
by 1.2 mm; for Dutch subjects: TR = 15 ms, TE = 7 ms, resolution =
0.98 by 0.98 by 1.0 mm). Some scans were done with an inplane
resolution of 0.5 mm by 0.5 mm; these scans were blurred to a resolu-
tion of 0.94 by 0.94 mm with trilinear interpolation using Analyze
AVW software (Mayo Foundation, Rochester, Minn., USA). Addi-
tionally, an axially oriented fast FLAIR sequence (for German sub-
jects: TR = 9,000 ms, TE = 110 ms, resolution = 0.94 by 0.94 by
6 mm; for Dutch subjects: TR = 9,000 ms, TE = 105 ms, resolution =
0.98 by 0.98 by 5 mm) was obtained.
Regional Distribution of WMH
An anatomical template was made to identify the borders of fron-
tal, parietal, temporal and occipital lobes, using the volumetric T1-
weighted sequence and Analyze AVW software (Mayo Foundation)
as previously described [30]. After editing the brain volume from all
nonbrain tissue, the anatomical borders of the 4 lobes were deter-
mined on the surface reconstruction of the brain, using anatomical
landmarks and simple geometrical constructions [30]. The frontal-
parietal border was defined by the sulcus centralis, and the frontal-
temporal border was determined by the sulcus lateralis. The parieto-
occipital, the temporo-occipital and the parietotemporal borders
were defined by a geometrical construction (fig. 1). The anatomical
template was reconstructed in the orientation and resolution of the
corresponding FLAIR weighted axial slices, using an affine transfor-
mation (AIR 3.08) [31]. WMH volumes were measured on the
FLAIR sequence. The lesions were semiautomatically traced, using a
region growing algorithm based on pixel intensity (fig. 1).
Lesions were manually edited, if visual inspection suggested
inconsistencies of the automated segmentation. The number of vox-
els within each lesion was summed automatically and multiplied by
the voxel size to obtain absolute values (mm3) for the lesions. The
outer borders of the lobes were easily identified on the axial FLAIR
sequence by comparing with the corresponding anatomical template.
Internal lobar boundaries were determined according to well-
described criteria (Psychiatry Research, Neuroimaging Section, ac-
cepted). The sum of lesions within each lobe gave the absolute WMH
load for each lobe. Lesions that crossed a lobar border were divided
along this border, and each part was attributed to the corresponding
lobe. Lobar WMH indices were calculated by dividing lobar WMH
volume by lobar volume. The total WMH index was calculated by
dividing the sum of WMH volumes across lobes by total brain vol-
ume. Total brain volume and lobar volumes were measured on the
T1-weighted volumetric scans according to a well-described method
(Psychiatry Research, Neuroimaging Section, accepted). All WMH
indices are expressed as percent ! 10–2 of lobar volume to simplify
reporting of numbers.
Neuropsychological Examination
Cognitive performance was investigated in a subgroup of 17 AD
and 6 VaD patients from the German center and a subgroup of 5
VaD patients from the Dutch center. German patients were tested
with the cognitive battery of the CERAD [32], Dutch patients were
tested using the cognitive battery of the Alzheimer’s Disease Assess-
ment Scale (ADAS) [33]. In addition to the ADAS, delayed 10-word
list recall and animal category verbal fluency were tested in Dutch
patients. To account for difference in the scoring of the CERAD and
the ADAS, scoring criteria of the CERAD were used for both Ger-
man and Dutch patients. To account for the different number of
items in the recognition and the naming task between German and
Dutch patients, percentage scores were calculated for these tasks by
dividing the number of correct responses by the maximum score.
Statistics
WMH indices were not normally distributed within groups, as
shown by the Schapiro-Wilks test and visual inspection of histo-
grams. To control for potential effects of age and center, between-
group differences in WMH load were assessed using univariate anal-
ysis of covariance with ranked regional WMH indices as dependent
variables and age, center and diagnosis as predictors. The regional
distribution of lobar WMH indices within each group was tested
using the Wilcoxon signed-ranks test. Correlations between WMH
indices and neuropsychological measures and age were controlled for
confounding effects of center, using partial correlation on the rank-
transformed WMH indices.
To determine the reliability of WMH measurements by different
raters, the intraclass correlation coefficient (ICC) was determined by
measuring WMH of 10 subjects by 2 independent investigators twice
(L.G. and Y.Z.), blinded to clinical diagnosis.
Results
As shown in table 2, after accounting for the effects of
age and center, total and regional WMH indices were sig-
nificantly higher in VaD patients than in healthy controls.
Furthermore, total and regional WMH indices were sig-
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Fig. 1. Surface map for tracing of lobar bor-
ders and axial FLAIR images with regional
segmentation. The letters A, B, C, D, E, H
and X denote the intersections of lines or ref-
erence points. A is the endpoint of the as-
cending branch of the sulcus lateralis. B is at
the parieto-occipital sulcus. Through C, the
center of the line AB, a line CH was drawn
perpendicularly to the line AB. D was deter-
mined along the line CH, where it intersects
the tissue/nontissue border of the brain. The
midpoint along line CD is denoted X, from
which a line was drawn to A and to B.
FLAIR images with semiautomatically
traced WMH are overlaid with the corre-
sponding anatomical template indicating
different regions of the brain (shown with
different line patterns, arrowheads are indi-
cating borders between lobes).
Table 2. Regional WMH indices in percent ! 10–2 of respective lobe volume
Comparison subjects
mean SD
AD patients
mean SD
VaD patients
mean SD
Ancova (d.f. = 2, 62)
F p
Total 1.55 2.12 3.77 3.96 24.53 28.19 13.4 !0.001a, b
Frontal 3.05 4.10 6.80 9.92 45.84 55.43 7.1 !0.002a, b
Parietal 2.87 5.15 7.02 5.68 48.57 56.16 18.8 !0.001a, b, c
Temporal 0.71 1.01 1.65 3.98 4.97 6.16 6.7 !0.002a, b
Occipital 0.58 1.14 3.34 5.99 8.99 13.16 4.4 !0.02a, c
Ancova = Analysis of covariance on rank-transformed values of WMH indices: overall group effect, covariates
were age and center.
a The WMH index was significantly higher in VaD than in controls (Ancova; d.f. = 1, 38; with age and center as
covariates, p ! 0.02).
b The WMH index was significantly higher in VaD than in AD (Ancova; d.f. = 1, 41; with age and center as
covariates, p ! 0.001).
c The WMH index was significantly higher in AD than in controls (Ancova; d.f. = 1, 43; with age and center as
covariates, p ! 0.03).
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Fig. 2. Regional distribution of WMH indices. Lobar WMH index =
WMH volume/lobar volume ! 104; * = higher compared to temporal
(p ! 0.001) and occipital WMH indices (p ! 0.05); † = higher com-
pared to occipital WMH index (p ! 0.001); 7 = higher compared to
temporal WMH index (p ! 0.05).
0
10
20
30
40
50
control AD patients
frontal
occipital
* †
* *
*
*
‡
parietal
temporal
VAD patients
lo
b
ar
 W
M
H
 in
d
ex
nificantly higher in VaD than in AD patients, with the
exception of the occipital WMH index. In the AD group,
parietal and occipital WMH indices were significantly
higher compared to controls. Using absolute WMH vol-
umes instead of WMH indices did not alter the signifi-
cance of these effects.
A regional analysis of WMH variations within each
group showed that WMH indices were generally higher in
the frontal and parietal lobes than in the temporal and
occipital lobes (fig. 2). A similar analysis with absolute
WMH volumes showed more WMH in the frontal lobe
than in the parietal lobe, and higher WMH volumes in the
parietal lobe than in the temporal and occipital lobes (p !
0.05 for all comparisons).
In the VaD group, the total WMH index and WMH
index of the frontal lobe were correlated with the MMSE
score, including control for a potential difference between
the centers (r = –0.53, p ! 0.01, and r = –0.47, p ! 0.001,
respectively; fig. 3a and b). Parietal and temporal WMH
indices were significantly correlated with drawing (r =
0.66, p ! 0.05, and r = 0.63, p ! 0.05, respectively; fig. 3c).
In the AD group, there were no significant correlations
between MMSE scores and total or regional WMH in-
dices (r between –0.13 and 0.25, p 1 0.24). Verbal catego-
ry fluency was correlated with the frontal lobe WMH
index (r = 0.51, p ! 0.05; fig. 3d). The significance of these
correlations remained unchanged when using absolute
WMH volumes. There were no significant correlations
between regional WMH indices and naming, verbal learn-
ing, recall or recognition in the AD and VaD groups.
Total WMH index and regional WMH indices in the
frontal, parietal and occipital lobes were positively corre-
lated with age in the AD group when controlling for center
(r = 0.63, p ! 0.001; r = 0.48, p ! 0.05; r = 0.52, p ! 0.01;
r = 0.44, p ! 0.05, respectively). Total and parietal WMH
were significantly correlated with age in the control group
when controlling for center (r = 0.45, p ! 0.05, and
r = 0.64, p ! 0.01, respectively). WMH indices did not
correlate with age in the VaD group. Correlations with age
remained unchanged for absolute WMH volumes.
The ICC for measurements of the total WMH index
was 0.996. The ICC for measurements of regional WMH
indices was 0.99 in the frontal lobe, 0.81 in the parietal
lobe, 0.998 in the temporal lobe and 0.72 in the occipital
lobe.
Discussion
In the present study, we used a new MRI-based meth-
od to measure regional WMH load. We found that WMH
indices, i.e. WMH volume normalized to lobar volume,
were more pronounced in VaD patients than in AD
patients and healthy controls. The distribution of WMH
across cerebral lobes was similar between groups, with
frontal and parietal lobes showing the highest and occipi-
tal and temporal lobes showing the lowest WMH load.
The WMH indices correlated with age in healthy controls
and AD patients, but not in VaD patients. Dementia
severity correlated with WMH indices in VaD, but not in
AD patients. There were correlations between domain-
specific cognitive impairments and regional WMH in-
dices in AD and VaD patients. To assure that the effects
in WMH indices were due to WMH changes and not to
changes in lobar volume, all analyses were repeated with
absolute WMH volumes.
One improvement of this study compared to earlier
studies is the use of a standardized protocol to quantita-
tively assess regional WMH load. Although several scales
exist for visual rating of WMH on MRI [34, 35], only few
of them include regional lobar distribution of WMH [14,
15, 36, 37]. Few methods were developed that provide
quantitative measures to examine WMH load on MRI,
and none of these examined regional WMH volumes [10,
18, 19, 38]. Interrater reliability for the measurement of
total WMH load with an ICC of 0.99 in our study com-
pares to previous quantitative methods with ICC ranging
from 0.97 [18] to 0.99 [19]. The ICC for regional WMH in
White Matter Hyperintensities in VaD
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Fig. 3. Cognitive measures and WMH indices in VaD and AD. Scatter plot of residuals of MMSE score and total (a)
and frontal (b) WMH indices controlled for center in the VaD group, of drawing score and parietal WMH index
controlled for center in the VaD group (c) and of fluency score and frontal WMH index controlled for center in the
AD group (d).
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our study ranged from 0.99 for the frontal lobe to 0.72 for
the occipital lobe. To our knowledge there are no previous
reports on the interrater reliability of regional WMH mea-
surements. Our method is based on a recently reported
segmentation technique to generate an anatomical tem-
plate for subsequent lesion allocation [30]. The frontal
lobe is segmented with reference to anatomical landmarks
only, whereas the other lobes are segmented by a combi-
nation of anatomical landmarks and a geometrical con-
struction. This may, at least in part, account for the differ-
ences in measurement accuracy of WMH across lobes.
Higher WMH indices in VaD patients compared to
AD patients and healthy controls, even after controlling
for age and center effects, are consistent with previous
studies [4, 39]. Parietal and occipital, but not total WMH
indices were significantly increased in AD patients com-
pared to healthy controls. This suggests that in AD certain
regions are more strongly involved in white matter pathol-
ogy than others. Such a region-specific WMH increase
may be overlooked when only total WMH load is exam-
ined. This may explain controversial findings on total
WMH load in AD from earlier studies [4, 7, 8, 40].
Regional distribution of WMH indices across lobes
was similar between groups. WMH indices were higher in
the frontal and parietal lobes than in the occipital and
temporal lobes in the demented patients and the healthy
controls. Earlier studies described a strong involvement of
the frontal and/or parietal lobes in demented patients and
healthy elderly subjects using semiquantitative rating
scales [4, 6, 15, 40, 41]. It has been suggested that over-
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representation of the frontal and parietal lobes on axial
slices might explain these findings [40]. Consistent with
this notion, the absolute frontal WMH volume was high-
est compared to all other lobes in all groups. But even
after normalization to lobar volumes, WMH load was
higher in frontal and parietal than in temporal and occipi-
tal lobes. Findings from other imaging modalities also
suggest that subcortical lesions may be most predominant
in the frontal lobe. In computer-assisted tomography
scans, leukoaraiosis was predominantly localized in the
frontal region in mildly to moderately demented VaD
patients, and only with severe dementia was leukoaraiosis
more diffusely distributed throughout the brain [42].
Frontal leukoaraiosis correlated with reduced frontal lobe
cerebral blood flow in mildly to moderately demented
VaD patients [42]. In diffusion-weighted MRI of VaD
patients the anterior region, particularly the frontal lobe,
exhibited more abnormalities in water diffusion than the
posterior regions of the brain [43]. Several neuropatholog-
ical studies found chronic ischemic lesions predominante-
ly in the frontal lobes and/or parietal lobes [24–26, 44, 45]
suggesting an increased susceptibility of these lobes for
white matter pathology.
In our VaD patients, dementia severity as measured by
MMSE correlated with total and frontal lobe WMH
indices. Furthermore, in a subgroup of the VaD patients
measures of drawing performance were correlated with
parietal and temporal lobe WMH indices. This location
agrees with a large range of neuropsychological studies on
patients with impaired drawing performance due to focal
cerebral lesions in the bilateral or right parietal lobe [46].
There were no correlations between measures of episodic
or semantic memory and regional WMH load. Similarly,
Cohen et al. [47] reported correlations of global WMH
load with visual-construction and executive-function
measures, but not with measures of memory and verbal
function in 24 VaD patients. This study, however, did not
assess regional WMH load. There were no correlations
between MMSE score and total and regional WMH in our
AD patients, consistent with other studies [13, 48]. This
suggests that either WMH in AD have not the same cogni-
tive significance as in VaD or that AD pathology obscures
the effect of WMH on cognition in AD. In AD patients
without cerebrovascular disease, the main reason for cog-
nitive impairment is AD-specific cortical pathology and
WMH may only contribute to a lesser degree to the cogni-
tive dysfunction.
In a subgroup of AD patients verbal category fluency
correlated with the frontal lobe WMH index. Verbal
fluency is a semantic function, involving speed of mental
processing and attention, and relays on prefrontal lobe
functional integrity [49]. It has been found that WMH
load, especially in the anterior region, is strongly corre-
lated with verbal fluency scores in patients with cerebro-
vascular disease and stroke [50] and that WMH in healthy
elderly subjects shows a strong correlation with perfor-
mance of frontal lobe functions [10, 12]. However, these
findings should be regarded as preliminary, because the
number of patients in each group was small.
The similar regional distribution of WMH in VaD, AD
and healthy aging suggests that these conditions might
share a common pathologic factor for the occurrence of
WMH. WMH in the AD and the control group may
reflect vascular comorbidity. Indeed, white matter pathol-
ogy in AD has been linked to ischemic changes [44] that
are superimposed on the AD-specific pathology. An age-
related increase in vascular comorbidity may underlie the
significant correlation between age and total WMH load
in AD patients and controls found in our and previous
studies [48, 51]. In contrast, disease-specific vascular
pathology would by far exceed an age-related increase in
vascular comorbidity in VaD patients, thereby masking
correlations between age and WMH load.
In the present study, we investigated healthy elderly
controls as well as demented patients with relatively low
cardiovascular comorbidity, such as hypertension or dia-
betes. Therefore, our results represent the effects of
healthy aging, pure AD and pure VaD on regional subcor-
tical lesions. For the same reason, however, one has to be
careful in conferring our findings on the general elderly
population, which has a much higher prevalence of car-
diovascular comorbidity.
Our findings do underscore the potential of regional
WMH volumetry to determine functional consequences
of subcortical pathology in different disease conditions.
We propose to use regional WMH volumetry in future
studies on the general elderly population.
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